Boston Micro Fabrication (BMF)
Leader in micro-precision 3D printing using proprietary Projection Micro Stereolithography (PμSL) technology, enabling ultra-high resolution manufacturing down to 2-micron precision for medical devices, electronics, and advanced research applications.
- CEO / Founder
- John Kawola
- Team Size
- 100-200
- Stage
- Late Stage (Series D)
- Total Funding
- $67M
- Latest Round
- Series D ($24M, Aug 2023)
- Key Investors
- ["National Manufacturing Transformation and Upgrading Fund", "Chuanghe Xincai Manufacturing Sector Fund", "Guotai Junan Innovation Investment", "North Summit Capital"]
Technology & Products
Key Products
["microArch S240 - 10μm resolution printer", "microArch S230 - High-precision production system", "microArch S140 - 2μm ultra-high resolution", "Horizon Technology - Metallic coating capability", "PμSL (Projection Micro Stereolithography) technology", "Custom precision materials for micro-parts", "Micro-part production services"]
Technological Advantage
BMF's technology enables the production of complex micro-scale parts that were previously impossible or prohibitively expensive to manufacture. This allows for rapid innovation in product design, especially in miniaturization for the electronics and medical device industries.
Market & Competition
Target Customers
Companies requiring ultra-high precision micro-parts including medical device manufacturers, electronics producers, biotech firms, and research institutions needing micron-scale 3D printed components.
Industry Verticals
["Medical Devices (implants, surgical tools, microfluidics)", "Electronics (connectors, sensors)", "Aerospace", "Biotech & Life Sciences", "Research & Academia", "Jewelry & Luxury Goods"]
Competitors
["Nanoscribe (a BICO company)","Microlight3D","UpNano GmbH"]